Rheumatic heart disease, if treated promptly and correctly, has little impact on life expectancy in most people, although there are no relevant studies or authoritative guidelines.
Rheumatic heart disease is characterized by lesions of the valves in the heart, resulting in stenosis or insufficient closure, on which the heart goes through a compensated phase to a decompensated phase, and ultimately severe heart failure that affects the quality of life.
During the evolution of rheumatic heart disease, various cardiac arrhythmias may occur, which may lead to sudden death and affect life expectancy.
Timely valve repair or valve replacement for rheumatic heart disease, regular postoperative anticoagulation, timely review of coagulation function and adjustment of drug dosage, etc., as long as there is no serious thrombosis or bleeding disorders, will have little impact on the life expectancy of the individual.
If rheumatic heart disease is left untreated, heart failure and arrhythmia may recur, and in severe cases, sudden death may occur at any time.